ALTO INGREDIENTS, INC. (ALTO) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.33%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.33% | Share-based compensation / revenue. Period ending 2026-06-30. $3.07M ÷ $943.33M × 100 ≈ 0.33% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 943.33M USD | |
| Stock-based compensation | 3.07M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 35.61M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $943.33M | $3.07M | $35.61M | (m) | (m) | 0.33% | (m) | (m) |
| 2026-03-31 | (m) | $916.07M | $2.88M | $18.88M | (m) | (m) | 0.31% | (m) | (m) |
| 2025-12-31 | (m) | $917.93M | $3.02M | $7.36M | (m) | (m) | 0.33% | (m) | (m) |
| 2025-09-30 | (m) | $922.31M | $2.89M | $-39.34M | (m) | (m) | 0.31% | (m) | (m) |
| 2025-06-30 | (m) | $933.14M | $3.04M | $-57.04M | (m) | (m) | 0.33% | (m) | (m) |
| 2025-03-31 | (m) | $951.17M | $4.06M | $-50.34M | (m) | (m) | 0.43% | (m) | (m) |
| 2024-12-31 | (m) | $965.26M | $4.36M | $-51.67M | (m) | (m) | 0.45% | (m) | (m) |
| 2024-09-30 | (m) | $1.00B | $4.83M | $-29.63M | (m) | (m) | 0.48% | (m) | (m) |
| 2024-06-30 | (m) | $1.07B | $4.97M | $-33.24M | (m) | (m) | 0.47% | (m) | (m) |
| 2024-03-31 | (m) | $1.15B | $4.29M | $-22.56M | $7.47M | (m) | 0.37% | -3.02× | Reported |
| 2023-12-31 | (m) | $1.22B | $3.90M | $-23.85M | $7.42M | (m) | 0.32% | -3.21× | Reported |
| 2023-09-30 | (m) | $1.28B | $3.50M | $-37.79M | (m) | (m) | 0.27% | (m) | (m) |
| 2023-06-30 | (m) | $1.30B | $3.27M | $-60.70M | (m) | (m) | 0.25% | (m) | (m) |
| 2023-03-31 | (m) | $1.34B | $3.41M | $-70.12M | (m) | (m) | 0.25% | (m) | (m) |
| 2022-12-31 | (m) | $1.34B | $3.33M | $-61.36M | (m) | (m) | 0.25% | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | $7.03M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | $25.34M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | $2.75M | $31.59M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $2.88M | $40.07M | $3.59M | (m) | (m) | 11.17× | Reported |
| 2021-09-30 | (m) | (m) | $2.95M | $-13.08M | $7.15M | (m) | (m) | -1.83× | Reported |
| 2021-06-30 | (m) | (m) | $2.89M | $22.13M | $10.92M | (m) | (m) | 2.03× | Reported |
| 2021-03-31 | (m) | (m) | $2.62M | $38.58M | $14.52M | (m) | (m) | 2.66× | Reported |
| 2020-12-31 | (m) | (m) | $2.68M | $9.85M | $17.94M | (m) | (m) | 0.55× | Reported |
| 2020-09-30 | (m) | (m) | $2.72M | $-12.19M | $19.34M | (m) | (m) | -0.63× | Reported |
| 2020-06-30 | (m) | (m) | $2.73M | $-61.97M | $20.31M | (m) | (m) | -3.05× | Reported |
| 2020-03-31 | (m) | (m) | $2.87M | $-87.26M | $20.78M | (m) | (m) | -4.20× | Reported |
| 2019-12-31 | (m) | (m) | $2.81M | $-74.68M | $20.21M | (m) | (m) | -3.70× | Reported |
| 2019-09-30 | (m) | (m) | $2.96M | $-66.97M | $19.27M | (m) | (m) | -3.48× | Reported |
| 2019-06-30 | (m) | (m) | $3.26M | $-48.67M | $18.30M | (m) | (m) | -2.66× | Reported |
| 2019-03-31 | (m) | (m) | $3.50M | $-56.11M | $17.36M | (m) | (m) | -3.23× | Reported |
| 2018-12-31 | (m) | (m) | $3.44M | $-51.54M | $17.13M | (m) | (m) | -3.01× | Reported |
| 2018-09-30 | (m) | (m) | $3.42M | $-31.92M | $16.66M | (m) | (m) | -1.92× | Reported |
| 2018-06-30 | (m) | (m) | $3.37M | $-23.38M | $16.29M | (m) | (m) | -1.44× | Reported |
| 2018-03-31 | (m) | $1.65B | $3.34M | $-20.32M | $14.81M | (m) | 0.20% | -1.37× | Reported |
| 2017-12-31 | (m) | $1.63B | $3.83M | $-25.59M | $12.94M | (m) | 0.23% | -1.98× | Reported |
| 2017-09-30 | (m) | $1.68B | $3.71M | $3.82M | $14.92M | (m) | 0.22% | 0.26× | Reported |
| 2017-06-30 | (m) | $1.65B | $3.59M | $869.00K | $14.97M | (m) | 0.22% | 0.06× | Reported |
| 2017-03-31 | (m) | $1.67B | $3.25M | $19.53M | $18.81M | (m) | 0.19% | 1.04× | Reported |
| 2016-12-31 | (m) | $1.62B | $2.62M | $23.51M | $22.41M | (m) | 0.16% | 1.05× | Reported |
| 2016-09-30 | (m) | (m) | $2.44M | $5.19M | $22.05M | (m) | (m) | 0.24× | Reported |
| 2016-06-30 | (m) | (m) | $2.29M | $-10.03M | $23.34M | (m) | (m) | -0.43× | Reported |
| 2016-03-31 | (m) | (m) | $2.10M | $-19.33M | $17.81M | (m) | (m) | -1.09× | Reported |
| 2015-12-31 | (m) | (m) | $2.02M | $-17.97M | $12.59M | (m) | (m) | -1.43× | Reported |
| 2015-09-30 | (m) | $1.07B | (m) | $-4.81M | $8.26M | (m) | (m) | -0.58× | Reported |
| 2015-06-30 | (m) | $965.52M | (m) | $23.61M | $4.22M | (m) | (m) | 5.59× | Reported |
| 2015-03-31 | (m) | $1.06B | (m) | $50.61M | $6.10M | (m) | (m) | 8.29× | Reported |
| 2014-12-31 | (m) | $1.11B | $1.84M | $91.38M | $9.44M | (m) | 0.17% | 9.68× | Reported |
| 2014-09-30 | (m) | $1.07B | (m) | $94.95M | $12.06M | (m) | (m) | 7.87× | Reported |
| 2014-06-30 | (m) | $1.02B | (m) | $82.37M | $15.46M | (m) | (m) | 5.33× | Reported |
| 2014-03-31 | (m) | $937.52M | (m) | $56.94M | $16.54M | (m) | (m) | 3.44× | Reported |
| 2013-12-31 | (m) | $908.44M | (m) | $18.91M | $15.67M | (m) | (m) | 1.21× | Reported |
| 2013-09-30 | (m) | $890.16M | (m) | $-5.76M | $15.65M | (m) | (m) | -0.37× | Reported |
| 2013-06-30 | (m) | $872.14M | (m) | $-12.11M | $14.50M | (m) | (m) | -0.84× | Reported |
| 2013-03-31 | (m) | $843.78M | (m) | $-23.97M | $13.62M | (m) | (m) | -1.76× | Reported |
| 2012-12-31 | (m) | $816.04M | (m) | $-31.66M | $13.05M | (m) | (m) | -2.43× | Reported |
| 2012-09-30 | (m) | $860.82M | (m) | $-20.54M | $12.86M | (m) | (m) | -1.60× | Reported |
| 2012-06-30 | (m) | $916.61M | (m) | $-10.51M | $13.55M | (m) | (m) | -0.78× | Reported |
| 2012-03-31 | (m) | $925.76M | (m) | $-5.26M | $14.08M | (m) | (m) | -0.37× | Reported |
| 2011-12-31 | (m) | $901.19M | (m) | $3.97M | $14.81M | (m) | (m) | 0.27× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $328.33M | (m) | $-13.77M | $6.80M | (m) | (m) | -2.02× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gevo, Inc. (GEVO) | United States | $0.345B | -1.72 |
| FutureFuel Corp. (FF) | United States | $0.225B | -6.53 |
| Comstock Inc. (LODE) | United States | $0.195B | -5.19 |
| XCF Global, Inc. (SAFX) | United States | $0.171B | -2.86 |
| CODEXIS, INC. (CDXS) | United States | $0.151B | -6.68 |
| AEMETIS, INC (AMTX) | United States | $0.128B | -1.95 |
| LanzaTech Global, Inc. (LNZA) | United States | $0.078B | 0.52 |
| TOMI Environmental Solutions, Inc. (TOMZ) | United States | $0.012B | |
| Westlake Chemical Partners LP (WLKP) | United States | $0.754B | 2.35 |
| Green Plains Inc. (GPRE) | United States | $1.054B | 8.70 |